ayush system.dnkg

23
AYUSH SYSTEM STRENGTH,AUTHENTICITY,CONTEMPORAR Y ISSUES&DEVELOPEMENT Dr.Jitendra Pandey

Upload: dr-jitendra-pandey

Post on 16-Apr-2017

123 views

Category:

Health & Medicine


2 download

TRANSCRIPT

Page 1: Ayush system.dnkg

AYUSH SYSTEMSTRENGTH,AUTHENTICITY,CONTEMPORARY

ISSUES&DEVELOPEMENT

Dr.Jitendra Pandey

Page 2: Ayush system.dnkg

STRENGTHHolistic approach to the

patient.Treating diseases without

complications.Monopoly for some

disease and disease segments like skin,hepatic disorders,renal disorders,menstrual,infertility etc.

Solution for almost everything,nothing is idiopathic.

Page 3: Ayush system.dnkg

STRENGTHCheap & accurate diagnostic techniques.

Wide range of medicines and medication for everyone : even a poor patient can be treated by using local medication plants and techniques.

Experience based medicine system practiced by our age old ancestors.

No dependency on expensive infrastructure ,machines or tools .

Page 4: Ayush system.dnkg

AUTHENTICITY ?Do you think this question is relevent ?

we all have seen results of AYUSH medications & treatment system ,it’s the oldest system practiced and tested by thousands of our ancenstors,but if you still feel so than next slide is for you…

Page 5: Ayush system.dnkg

SOME MIRACULOUS RESULTS

Page 6: Ayush system.dnkg
Page 7: Ayush system.dnkg

EVALUATION OFFREE-RADICAL SCAVENGING ACTIVITY

OF SWARNA BHASMA

Result• Swarna bhasma treated animals showed significant increase of SOD activity in serum and liver• The treated animals’ serum and liver homogenate prevented NADH oxidation significantly compared to control animals

Measurement in units/ ml of bloodCatalase

Serum LiverSwarna bhasma 1.8 7.4 39.73Control 0.508 4.23 22.02

SOD

4weeks treatment

Page 8: Ayush system.dnkg

VASANT KUSUMAKAR RAS IN DIABETIC NEUROPATHY Study Center:

SVS Marwari Hospital and Chittaranjan Hospital, Calcutta.

Investigators: Dr. AK Jain & Dr. TK Das

Study Design: Open Labeled

Study Population: Resistant Diabetes of both NIDDM & IDDM Types Aged Between 30 - 75 years, Both Genders Basal Blood Sugar NLT 170 mg/dL

Page 9: Ayush system.dnkg

Dibetic neuropathy & retinopathy(Double blind placebo controlled study)

Study Center:–Department of Kaya Chikitsa, R. A. Podar Medical College, Mumbai

Investigators:–Dr. K.R.Kohli, Dr. Sanjay .M. TamoliStudy Design:–Double blind, placebo controlledStudy Population:–60 patients, 30 each in Diabetic retinopathy and Diabetic neuropathy divided further in 2 groups of Drug and Placebo–Controlled Blood Sugar levels

Page 10: Ayush system.dnkg

Effect on hasta - pada daha

00.20.40.60.8

11.21.41.6

Initi

al

Afte

r 8w

eeks

Hasta padaDaha

Page 11: Ayush system.dnkg

Vasant kusumakar ras

Before t/t

After t/t

Page 12: Ayush system.dnkg

Marked improvement Before t/t After t/t

Page 13: Ayush system.dnkg

Conclusion : Imposible for modern systemSymptomatic improvement was found in

17 patients of Diabetic retinopathy treated with Vasant Kusumakar Ras

Fundus photographs of 8 patients show reversal in retinopathy, out of these 8, in 4 patients the reversal is more significant

No adverse effect of the drug was noticed after administration for a period of 12 weeks

Page 14: Ayush system.dnkg

If you are not satisfied than see some more..

Page 15: Ayush system.dnkg

Swarna yukta Ras-RasayanClinical trails confirmed

Vasant Kusumakar Ras Hypoglycemic drug Potent anti- oxidant, delays Diabetic complicationsVrihat Vat Chintamani Ras Anti-Inflammatory drug Immuno-modulatory drugMaha Lakshmi Vilas Ras Positive results in SinusitisShwas Kas Chintamani Ras Childhood Asthma

Page 16: Ayush system.dnkg

Lauhasava:

Clinical trial conducted at National Institute of Nutrition, Hyderabad

Findings • Lauhasava is effective in regenerating

hemoglobin in iron deficiency models• The serum concentration of Iron with

Lauhasava is higher than that of Ferrous sulphate molecule

Page 17: Ayush system.dnkg

CONTEMPORARY ISSUES SYSTEM RELATED Insurance sectors are not

covering ayush therapies .No policies for

reimbursement of patients bills in state and central government.

No proper orientation ,trainings, financial supports to establish ayurvedic centers.

No specific jobs and departments in Army,railway etc.

Page 18: Ayush system.dnkg

CONTEMPORARY ISSUES DRUGS RELATEDNo specific DRUG CONTROL resulting great difference in quality of drugs ,varies company to company.

Extinction of plant species many plant species are in danger.

Unstanderized manufacturing system, resulting quality difference in same medicines( batch to batch ).

Companies are reducing their drug ranges as many of classical drugs are not available in general market.

Page 19: Ayush system.dnkg

QUALITY OF EDUCATION & JOB OPPORTUNITIESQuality of education is very poor ,students are

not clinic ready,students should get proper clinical exposure.

Study should be advanced and job oriented.No job opportunity for new graduates , no one

is ready to fund their startups .Salary of a B.A.M.S graduate is not more than

an unskilled laborer ,some are even struggling for their basic needs.

You can see daily adds regarding jobs Ayurveda doctor 10,000 to 18000 p.m resulting….

Page 20: Ayush system.dnkg

Who is responsible for this…?

Page 21: Ayush system.dnkg

Gene mapping – natural hybridization is the challenge .

Six sigma standards - every batch of medicine should be equally effective.

Bio resource development – extinction of plant species is the challenge.

Pre clinical ,clinical studies of sastrokta & patent medicines – EVIDENCE BASED MEDICINE IS THE CHALLENGE.

Using I.C.P.M.S – HEAVY METAL IS THE CHALLENGE.

Developments

Page 22: Ayush system.dnkg

CHECK FOR MICROBES & GAMMA ERADICATION – MICROBIAL GROWTH IS THE CHALLENGE.

STABILITY TESTING USING MODERN TECDHNIQUES LIKE THERMOLAB ETC. – STABILITY OF PACKED DRUGS UNDER VARIOUS ENVIRONMENTAL CONDITION IS THE CHALLENGE.

QUALITY OF PACKAGING MATERIAL .NEW PRODUCT DEVELOPMENT – CHANGE IN

CONSUMPTION PATTERN IS THE CHALLANGE (MORE PALATABLE DRUG FORMULATIONS)

Developments

Page 23: Ayush system.dnkg